Figure 4.
Neuroprotective effect of scopoletin against glutamate-induced cell death in HT22 cells. (a) control group, (b) glutamate treated group, (c) glutamate + trolox treated group, (d) glutamate + scopoletin (100 μM) treated group
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.